GOLD SPONSORS
CONTENT SPONSORS
CONTENT SPONSORS
SUPPORTED BY
Digital transformation has had significant support amongst our executive leadership. The last 18 months has also seen considerable investment being made in technology, upskilling and processes to ensure our labs are fit for modern biopharma research.
However, we are still facing some fundamental challenges in transitioning to a truly digital and data driven industry. Not least are legacy systems, poor data quality, disconnected datasets, lack of skills and archaic, siloed, working practices.
How are our leaders addressing these important challenges and what lessons have they learnt from their own internal initiatives? More importantly, what advice and guidance can they give us to ensure that our scientists have the tools at their fingertips to allow them to innovate in a digital world.
Improving the customer experience with innovative technologies and enhancements
Modernizing legacy applications to drive valuable data insights
Leveraging platform technology to drive laboratory orchestration
Empowering data integrity and the value of streamlining processes and workflows
Driving scientific discoveries with the support of laboratory automation and integration
Developing a Data and Digital Journey for Research in the Lab
Kristen Ferrara, Global Head of Scientific Informatics; R&D / Vaccines IT and Digital, Takeda
Building a comprehensive digital strategy
Adam Wheeler, Customer Enablement, Digital Solutions, Thermo Fisher Scientific
Creating Space for Innovation
Lab of the future program at CSL spanning 3 continents.
The session will also include how robotics and automation and discussion around the type of workforce need for the future.
Vicky Pirzas, VP Recombinant Product Development, Managing Director R&D, CSL Behring Innovation
The Digital Lab – Convergence of the Internet and Industry 4.0
Embracing fundamental concepts from Industry 4.0
The Connected Lab
Laying the foundation for AI technologies
Bob Gantzer, Director of Lab Automation, Beam Therapeutics
David Fuller, CEO & Co-Founder, Artificial
Global Digital Strategy for Biologics at Sanofi
Digital Foundation for biologics
Platform and Systems
Scientific innovation Workstream
Dr. Yves Fomekong Nanfack, Director, Head of Operations Digital Biologics Platform, Sanofi
14:30 EST
Data + Intelligence for Scientific Enterprises
Digital Transformation for Life Science Operations
The Unified Data Model
Recent Case Studies
Vasu Rangadass, President and CEO, L7 Informatics
Leveraging the Digital Age in Procurement Supporting the Lab of the Future
A sourcing view of the future
Optimizing the traditional and the transition to new models
Leverage Digital approaches that partner the scientific needs with future designs
How to think about our impact and where to focus
Mark Burfoot, VP Senior Partner, Head of Research Procurement, Novartis
14:30 EST
The science to lab management: driving digitalization and lab operations
Even with the latest digital research tools and other advanced systems available today, organisations still find themselves hampered by the cost, time and effort it takes to efficiently manage lab operations and move treatments from discovery to delivery faster.
Scott Streeseman, Director – Lab and Production Services, Avantor
Development Labs of the Future: How do we get there from here?
Leah O’Brien, Senior Product Director, Development Lab Systems, GSK
Why Data Maturity is Essential to the Lab of the Future
Noelle Strubczewski, Associate Director, Equipment Management and Reliability, Ultragenyx Pharmaceuticals
Sridhar Iyengar, CEO & Founder, Elemental Machines
What can be learned from industry success stories
James Connelly, CEO, MY Green Lab
Case Studies from Takeda
Sriman Banerjee, Head of Packaging Development & Commercial Device Engineering, Takeda
16:40 EST
Digitalization and Connectivity on the Path to Net Zero
Priya Vijayakumar, CEO, Watt IQ
The BMS R&ED IT Digital Greenhouse – Transform & Accelerate the way we innovate
The Greenhouse is a safe place to innovate and grow ideas. It is a virtual space where R&ED IT can work closely with business users to experiment with technology to solve challenges and create new opportunities.
Engage >> Shape >> Experiment >> Readout
Regulatory document automation – freeing up the scientists by improving the submission applications process
The Live Lab sessions are a series of interactive moderated discussion sessions, held in the exhibition and refreshment area, where physical attendees can gather to debate and discuss some of the pressing themes and big picture challenges to delivering the Lab of the Future
Live Lab session 1)
Moderated by Geoff Parker, Scimcon Pharma 2040 – Building the scientist of the future
Technology is changing the landscape of the lab dramatically, what does this mean for our scientist’s day to day work? What will ‘Scientists spending more time doing science’ mean in 10 or 20 years?
Live Lab Session 2)
Moderated by Roger Shaw and Joost van Kempen, Digital Lab Consulting – “How to be ready for an AI & ML world”
What do people think is needed. Practical steps to getting there
Live Lab session 3)
Moderated by Roger Frechette, NPA Associates: Delivering the Lab of the Future – top 5 areas for cross industry collaboration
Focus on the common challenges that need to be addressed delivering a future proof lab. Identifying pre competitive problems that could be addressed collaboratively in order to find common solutions.
There can be no greater mission than to achieve better health for our global citizens through innovation in medicine. How can we utilize technology and our internal research capabilities to translate our science into transformative medicines? How can we unify platforms and processes within the Lab of the Future to enable our scientists to deliver on this mission?
Digitization of the lab – AstraZeneca Case Study
What is our vision of a lab of the future
What are our focus areas for investment
What are our digital capabilities that underpin these focus areas
Dan Paulson, Senior Enterprise Architect, AstraZeneca
Robin Brouwer, Digital Lab Capability Leader, AstraZeneca
11:50 EST
Digital Chemistry in Action: The Lab of the Future is Less Lab
Optimizing the use of wet lab synthesis and assays
Utilising highly predictive computational models for design, ideation, collaboration, and project management
Case studies and success stories from drug discovery programs web agenda for bullet points
Dana Vanderwall, Executive Director of Enterprise Informatics, Schrödinger
Transformative R&D Technologies to Bring Innovative Medicines to Patients Faster
Computer-assisted synthetic planning for enhanced NCE production
From experiment planning to execution and data modeling
Automated integration of lab instrument data,
Building corporate knowledge and enabling data mining
The importance of scientific data architecture
The virtual lab companions
Dom Hebrault, Digitalization Lead, Boehringer Ingelheim
Augmented Experiments – Using AI to shift R&D into a higher gear
The impact enterprise AI can have on an organization
Considerations to validate, introduce, and scale disruptive technology
How to transform your organization with AI today
Luigi Gentile, Chief Revenue Officer, BenchSci
Image data analytics using virtualization, an on-premise, scalable microscopy case study
Shoh Asano, Principal Scientist, Pfizer
12:50 EST
Natural Language Processing – An assessment of current capabilities and opportunities for pharma
Peter Henstock, ML & AI Technical Lead, Pfizer
My five critical learnings as a business owner of a drug development-wide ELN
Democratization of data; from novice to expert
Is it a tool for them or a toy for you?
Changing the ELN paradigm
If you cannot show them, you have lost them – working demos, not slides
Building enterprise solutions from the bottom-up
Douglas Scheesley, Scientific Leader, GSK
12:50 EST
Take Control of Analytical Data Marshaling…on Your Terms
Alternatives to black-box enterprise-level analytical data systems
Homogenized analytical data management dashboards
Managing analytical data marshaling and building workflows
Richard Lee, Director, Core Technology Innovation and Informatics Strategy ACD/Labs
Empowering scientists through modern lab Informatics solutions
Delivering the benefits of shared and harmonised data
Brendan Faherty, Principal Solutions Architect, Genentech
Evan Anderson, Manager, Data Architects, TetraScience
The development and delivery of modern, data-centric, reusable and shareable software solutions at Genentech
Sally Madden, Bioinformatics Software Engineer, Genentech
14:40 EST
Topic to be finalised
Kara West, Lab Informatics Specialist, MilliporeSigma
Lab of the Future – tales from the trenches
Brian Gilman, VP Research Technology, Vertex
Implementing Robust Laboratory and Manufacturing Computerized Systems for Product Testing
Discuss importance of standardized imaging
Discuss system security
Discuss Validation/Qualification/Change Management
Discuss Maintenance/Periodic Monitoring
Cindy Novak, Senior Manager, Lab Computing Systems, Bristol Myers Squibb
Better Assay Development: Do it Like You’re Already Screening
Screening assays target repeatability, but the use of manual processes during the development phase can get in the way of that goal
Adding flexibility to workflows used for screening data capture to make them usable for assay development can help us do better science and reach the finish line faster
Jennifer Heymont, Associate Director, Scientific Informatics Eisai
15:30 EST
Sourcing Chemicals in the Lab of the Future
Development of a new system that streamlines the process for finding, ordering and delivering any commercially available chemical, including synthesis on demand
Leverage suppliers from around the world
Integration with internal systems and research workflows
Joseph Pease, Principal Scientific Manager, Genentech
The challenge of managing the growth of IoT, smart devices and other disruptive technologies
